Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron

$
0
0
BOTHELL Wash. Feb. 14 2012 PRNewswire SCOLR Pharma Inc. OTCQB SCLR announced today that RedHill Biopharma Ltd. a license partner that had previously obtained the exclusive worldwide rights to use SCOLR's patented technology to develop a new version of ond...

Viewing all articles
Browse latest Browse all 2985

Trending Articles